Viewing Study NCT00610792


Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2026-03-03 @ 4:12 PM
Study NCT ID: NCT00610792
Status: WITHDRAWN
Last Update Posted: 2009-07-14
First Post: 2008-01-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module